FIH Partners advises Novo Holdings on acquisition of Ellab, a global leader in high-end validation and monitoring solutions for the life science industry.
Headquartered in Hillerød, Denmark, Ellab provides Validation- and Monitoring Solutions and Services used for measuring and documenting critical parameters such as temperature, pressure and carbon dioxide in mainly biotech and pharma processes. The Company serves all of the top 20 biotech companies and all of the top 40 pharma companies globally helping them ensure consumer safety and regulatory compliance, while reducing time to market and the risk of product loss.
FIH Partners acted as exclusive M&A advisor to Novo Holdings on the transaction.
